# Ferrer Freeman & Co

Ferrer Freeman & Co is an Asset Manager based in Greenwich, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Greenwich, United States
- **Region:** North America
- **Address:** Greenwich, CT, United States
- **Founded:** 1995
- **Assets under management:** Undisclosed
- **Website:** ferrerfreeman.com

## Regulatory record

- **Reports private funds:** No

## About

Carlos Ferrer and David Freeman founded Ferrer Freeman & Co in 1995 after careers at GE Capital's equity unit. The firm set up in Greenwich, Connecticut with a deliberate mandate: invest only in healthcare. That constraint was unusual for the mid-1990s, when most middle-market private equity firms ran generalist portfolios. The founders structured the firm as a partnership that would concentrate capital, operational energy, and sector relationships into one vertical. FFC pursues growth equity and buyout investments in commercial-stage healthcare companies across three sub-sectors: healthcare services, medical devices, and specialty pharmaceuticals. The firm typically writes equity checks of $15 million to $50 million per deal, targeting companies with $5 million to $50 million in revenue. Portfolio positions have historically included companies in outsourced pharmaceutical services, ambulatory surgery centers, specialty physician practice management, and diagnostic imaging. The firm exited several portfolio companies through strategic sales to larger healthcare consolidators, a pattern consistent with its focus on building platforms attractive to strategic acquirers. FFC closed its fourth fund, Ferrer Freeman & Co IV, in 2006, at roughly the same scale as prior vehicles. The firm continued managing its portfolio through the late 2000s and 2010s, largely harvesting existing investments rather than deploying fresh capital. In September 2013, the firm realized a significant exit when portfolio company Medpace, a clinical research organization, completed its initial public offering on the Nasdaq — a transaction that marked the maturation of an investment held for nearly a decade. FFC illustrates a mid-market private equity model that bet entirely on sector specialization before it became standard industry practice. Unlike generalist firms that later added healthcare-dedicated teams, FFC was born into the constraint. The firm's partnership structure survived the departure of founding capital sources and the structural shift from GE-linked origins to independent institutional fundraising. Its post-deployment posture — managing legacy assets without successive fundraises — matches a pattern of founder-led firms that wind down investment activity but maintain fiduciary responsibility for remaining portfolio companies.

## Sectors

- Healthcare Services
- Medical Devices
- Pharmaceuticals
- Diagnostics

## People

- Carlos Ferrer — Co-Founder & Managing Partner
- David Freeman — Co-Founder & Managing Partner

## Questions

### How is Ferrer Freeman & Co structured?

Ferrer Freeman & Co is structured as a traditional middle-market private equity partnership led by its two original co-founders, Carlos Ferrer and David Freeman. The firm raised four institutional funds from limited partners over its active fundraising period, then transitioned into portfolio management without raising additional capital. This structure stands apart from both single-family offices (which manage proprietary capital) and larger institutional platforms that pursue continuous fundraising cycles.

## Related profiles

- [Foxfield](https://altss.com/profile/foxfield)
- [FGF Management](https://altss.com/profile/fgf-management)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/ferrer-freeman-and-co

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology